Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Domchek

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Imaging|September 23, 2019
Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer TherapyJenica N Upshaw, Brian Finkelman, Rebecca A Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Multidisciplinary meeting on male breast cancer: summary and research recommendationsLarissa A Korde, Jo Anne Zujewski, Leah Kamin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Breast (Edinburgh, Scotland)|June 15, 2010
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriersJessica Dennis, Parviz Ghadirian, Julian Little, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
JMIR Formative Research|May 14, 2025
Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing StudyPhillip Trieu, Dominique Fetzer, Briana McLeod, et al.
Cancers|July 20, 2021
Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> CarriersWojciech Marciniak, Tomáš Matoušek, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
HGG Advances|August 26, 2024
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventionsLillian Phung, Elisabeth Wood, Brian Egleston, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Imaging|September 23, 2019
Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer TherapyJenica N Upshaw, Brian Finkelman, Rebecca A Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Multidisciplinary meeting on male breast cancer: summary and research recommendationsLarissa A Korde, Jo Anne Zujewski, Leah Kamin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Breast (Edinburgh, Scotland)|June 15, 2010
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriersJessica Dennis, Parviz Ghadirian, Julian Little, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
JMIR Formative Research|May 14, 2025
Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing StudyPhillip Trieu, Dominique Fetzer, Briana McLeod, et al.
Cancers|July 20, 2021
Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> CarriersWojciech Marciniak, Tomáš Matoušek, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
HGG Advances|August 26, 2024
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventionsLillian Phung, Elisabeth Wood, Brian Egleston, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Pageof 10